RIPK1 and neoplasm: Overall, our data suggest that early phosphorylation of TNFR1 signaling complex components is crucial for tumor survival under T cell challenge and indicate that manipulating RIPK1 checkpoints may be a viable strategy to enhance T cell–mediated killing.